MAPK3 and pulmonary arterial hypertension: We propose that in pericytes from PAH patients, PDE2 selectively reduces a cAMP pool which is linked to the PDGF-BB -induced PKC and ERK1/2 activation, thereby inhibiting CAD phosphorylation.